Joseph E. Glass, PhD, MSW

Glass_Joseph_E_205x287.jpg

“We need to increase the reach of addiction treatment within health care systems. Many more people could benefit from effective care.”

Joseph E. Glass, PhD, MSW

Associate Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Joe Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.

Dr. Glass’ research seeks to understand how effective health care interventions for unhealthy alcohol and drug use can reach more people. His research seeks to answer these questions:

  • Why do so few people receive help for their unhealthy drinking and drug use?
  • How can we change this?
  • How can health systems make better use of effective treatments?
  • In what ways could our current treatments for addiction be improved?
  • Is care for unhealthy alcohol use delivered equitably?

Much of Dr. Glass’ recent work, funded by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and Kaiser Permanente, is studying approaches for routinely using smartphone and web-based treatments for unhealthy alcohol and drug use in health care. After receiving an MSW from the University of Michigan, Dr. Glass spent three years as a social worker at the Veterans Affairs Ann Arbor Healthcare System. As a licensed clinical social worker in a large mental health clinic, he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders. Much of his research is driven by his clinical experiences, considering the many people struggling with both mental health difficulties and unhealthy substance use who have yet to receive addiction treatment. 

Dr. Glass is an affiliate assistant professor of health services and of psychiatry and behavioral sciences, at the University of Washington.

Research interests and experience

Recent publications

Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Editorial: COVID-19 and its impact on SUD treatment. J Subst Abuse Treat. 2020 Oct;117:108091. doi: 10.1016/j.jsat.2020.108091. PubMed

Oh H, Nicholson HL Jr, Koyanagi A, Jacob L, Glass J. Urban upbringing and psychiatric disorders in the United States: a racial comparison. Int J Soc Psychiatry. 2020 Aug 21:20764020950781. doi: 10.1177/0020764020950781. Online ahead of print. PubMed

Glass JE, Williams EC, Oh H. Racial/ethnic discrimination and alcohol use disorder severity among United States adults. Drug Alcohol Depend. 2020 Aug 10;216:108203. doi: 10.1016/j.drugalcdep.2020.108203. PubMed

Montgomery L, Friedmann P, Abraham A, Evans E, Glass J, Ilgen M. Editorial: Health equity in substance use disorder treatment. J Subst Abuse Treat. 2020 Aug 8:108101. doi: 10.1016/j.jsat.2020.108101. Online ahead of print. PubMed

Matson TE, Lapham GT, Bobb JF, Johnson E, Richards JE, Lee AK, Bradley KA, Glass JE. Cannabis use, other drug use, and risk of subsequent acute care in primary care patients. Drug Alcohol Depend. 2020 Aug 8;216:108227. doi: 10.1016/j.drugalcdep.2020.108227. [Epub ahead of print]. PubMed

 

healthy findings blog

LHS_Buprenorphine-TEAM-mtg-Amy-Lee__1col.jpg

Partnering to advance lifesaving care

Amy Lee describes how the LHS Program is helping KP Washington track and improve treatment for opioid use disorder.

innovating care

Cannibus-use-Gwen-Lapham-blog_1col.jpg

Asking patients about cannabis may benefit overall health

Drs. Lapham and Bradley find frequency of cannabis use can be tied to other behavioral health patterns and needs.